Resolution Capital Ltd increased its holdings in shares of HCP, Inc. (NYSE:HCP) by 16.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,364,390 shares of the real estate investment trust’s stock after purchasing an additional 1,021,965 shares during the quarter. HCP makes up approximately 7.5% of Resolution Capital Ltd’s portfolio, making the stock its 3rd biggest position. Resolution Capital Ltd owned approximately 1.54% of HCP worth $230,505,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of HCP. Cohen & Steers Inc. lifted its stake in HCP by 317.6% in the third quarter. Cohen & Steers Inc. now owns 16,962,610 shares of the real estate investment trust’s stock valued at $446,456,000 after buying an additional 12,900,457 shares during the last quarter. Deutsche Bank AG lifted its stake in HCP by 1,073.7% in the fourth quarter. Deutsche Bank AG now owns 10,704,554 shares of the real estate investment trust’s stock valued at $298,971,000 after buying an additional 9,792,507 shares during the last quarter. Zimmer Partners LP purchased a new stake in HCP in the fourth quarter valued at approximately $230,959,000. Barrow Hanley Mewhinney & Strauss LLC lifted its stake in HCP by 73.8% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 14,036,864 shares of the real estate investment trust’s stock valued at $392,050,000 after buying an additional 5,960,734 shares during the last quarter. Finally, Norges Bank purchased a new stake in HCP in the fourth quarter valued at approximately $128,473,000. Hedge funds and other institutional investors own 95.64% of the company’s stock.
Shares of HCP stock traded down $0.55 during trading hours on Wednesday, hitting $29.28. 87,635 shares of the company were exchanged, compared to its average volume of 3,154,448. HCP, Inc. has a 1 year low of $21.80 and a 1 year high of $32.23. The company has a debt-to-equity ratio of 0.85, a current ratio of 0.64 and a quick ratio of 0.64. The stock has a market capitalization of $13.98 billion, a PE ratio of 16.03, a price-to-earnings-growth ratio of 7.68 and a beta of 0.46.
HCP (NYSE:HCP) last released its quarterly earnings results on Wednesday, February 13th. The real estate investment trust reported $1.73 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.43 by $1.30. HCP had a return on equity of 18.40% and a net margin of 57.41%. The business had revenue of $441.92 million during the quarter, compared to analysts’ expectations of $445.81 million. During the same quarter in the prior year, the business earned $0.48 earnings per share. The company’s quarterly revenue was down .3% compared to the same quarter last year. As a group, equities research analysts anticipate that HCP, Inc. will post 1.74 EPS for the current year.
A number of equities research analysts have weighed in on the company. Zacks Investment Research upgraded HCP from a “sell” rating to a “hold” rating in a research note on Thursday, March 14th. Morgan Stanley set a $32.00 price objective on HCP and gave the company a “hold” rating in a research note on Thursday, March 28th. BMO Capital Markets reiterated a “buy” rating and issued a $33.00 price objective on shares of HCP in a research note on Wednesday, February 13th. TheStreet upgraded HCP from a “c” rating to a “b-” rating in a research note on Wednesday, February 13th. Finally, Robert W. Baird upgraded HCP from a “neutral” rating to an “outperform” rating in a research note on Monday, January 7th. One analyst has rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $28.95.
TRADEMARK VIOLATION NOTICE: This article was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this article on another domain, it was copied illegally and republished in violation of international trademark & copyright legislation. The original version of this article can be accessed at https://www.dispatchtribunal.com/2019/04/17/hcp-inc-hcp-position-raised-by-resolution-capital-ltd.html.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Featured Article: Risk Tolerance and Your Investment Decisions
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.